Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization

详细信息    查看全文

• 作者：Reshani H. Perera ; PhD ^{rhp26@case.edu} ; Hanping Wu ; MD ; PhD ^{hanping.wu@case.edu} ; Pubudu Peiris ; PhD ^{Pmp48@case.edu} ; Christopher Hernandez ; BS ^{Cxh404@case.edu} ; Alan Burke ; BS ^{alan.burke@case.edu} ; Helen Zhang ; BS ^{yxz443@case.edu} ; Agata A. Exner ; PhD ; ^{Agata.exner@case.edu}
• 关键词：Ultrasound contrast agent ; Nanobubble ; Microbubble ; Extravasation ; Cancer
• 刊名：Nanomedicine: Nanotechnology, Biology and Medicine
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：13
• 期：1
• 页码：59-67
• 全文大小：1410 K
• 卷排序：13

文摘

The design of nanoscale yet highly echogenic agents for imaging outside of the vasculature and for ultrasound-mediated drug delivery remains a formidable challenge. We have previously reported on formulation of echogenic perfluoropropane gas nanobubbles stabilized by a lipid-pluronic surfactant shell. In the current work we describe the development of a new generation of these nanoparticles which consist of perfluoropropane gas stabilized by a surfactant and lipid membrane and a crosslinked network of N,N-diethylacrylamide. The resulting crosslinked nanobubbles (CL-PEG-NB) were 95.2 ± 25.2 nm in diameter and showed significant improvement in stability and retention of echogenic signal over 24 h. In vivo analysis via ultrasound and fluorescence mediated tomography showed greater tumor extravasation and accumulation with CL-PEG-NB compared to microbubbles. Together these results demonstrate the capabilities and advantages of a new, more stable, nanometer-scale ultrasound contrast agent that can be utilized in future work for diagnostic scans and molecular imaging.